We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ve Bionic Etf | LSE:CYBG | London | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.385 | 17.198 | 17.394 | 0 | 12:06:08 |
TIDMCYBG TIDM11IO
RNS Number : 4113L
CYBG PLC
30 September 2016
CYBG PLC
(Company)
30 September 2016
Total Voting Rights
Pursuant to the Financial Conduct Authority's (FCA's) Disclosure and Transparency Rule 5.6.1, the Company notifies the market that as at close of business on 29 September 2016 the issued capital of the Company consists of 129,432,652 ordinary shares each with one vote and 752,099,200 CHESS Depository Interests each with one vote. There are no shares held in Treasury.
Therefore the total number of voting rights in the Company is 881,531,852.
The above total number of voting rights may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in the Company under the FCA's Disclosure and Transparency Rules.
Enquiries
Investors and Analysts
John Crosse 07917 172535
Head of Investor Relations john.crosse@cybg.com
Company Secretary
Lorna McMillan 07834 585436
Company Secretary lorna.mcmillan@cybg.com
Media Relations
Press Office 0800 066 5998
press.office@cybg.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRGMGFLVGMGVZM
(END) Dow Jones Newswires
September 30, 2016 12:02 ET (16:02 GMT)
1 Year Ve Bionic Etf Chart |
1 Month Ve Bionic Etf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions